These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33973136)

  • 41. Liver macrophages mediate effects of downhill running and caloric restriction on nonalcoholic fatty liver disease of high fat diet-fed mice.
    Ai L; Luo W; Yuan P; Liu L; Zhou Y
    Life Sci; 2020 Sep; 256():117978. PubMed ID: 32553927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.
    Wan J; Benkdane M; Teixeira-Clerc F; Bonnafous S; Louvet A; Lafdil F; Pecker F; Tran A; Gual P; Mallat A; Lotersztajn S; Pavoine C
    Hepatology; 2014 Jan; 59(1):130-42. PubMed ID: 23832548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration.
    Zhang Y; Zhou X; Liu P; Chen X; Zhang J; Zhang H; Li S; Chen Y; Song X; Wang J; Zeng H; Zhang X; Tang C; Yu C; Li Y; Xu C
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G531-G542. PubMed ID: 33470903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulated Pdx1 and MafA Contribute to β-Cell Function Improvement by Sleeve Gastrectomy.
    Li F; Cao H; Sheng C; Sun H; Song K; Qu S
    Obes Surg; 2016 Apr; 26(4):904-9. PubMed ID: 26781599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients.
    Ayloo S; Guss C; Pentakota SR; Hanna J; Molinari M
    Transplant Proc; 2020; 52(1):276-283. PubMed ID: 31889539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
    Liou CJ; Lee YK; Ting NC; Chen YL; Shen SC; Wu SJ; Huang WC
    Cells; 2019 May; 8(5):. PubMed ID: 31083505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sleeve Gastrectomy with Bypass of Proximal Small Intestine Provides Better Diabetes Control than Sleeve Gastrectomy Alone Under Postoperative High-Fat Diet.
    Cheng Y; Huang X; Wu D; Liu Q; Zhong M; Liu T; Zhang X; Zhang G; Hu S; Liu S
    Obes Surg; 2019 Jan; 29(1):84-92. PubMed ID: 30251097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.
    Salman MA; Salman AA; Abdelsalam A; Atallah M; Shaaban HE; El-Mikkawy A; Omar MG; Elshenoufy M
    Obes Surg; 2020 Jan; 30(1):87-95. PubMed ID: 31372873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
    de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
    Front Immunol; 2019; 10():2926. PubMed ID: 31998283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria.
    Baldwin D; Chennakesavalu M; Gangemi A
    Surg Obes Relat Dis; 2019 Dec; 15(12):2123-2130. PubMed ID: 31711944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive Assessment of the Effects of Sleeve Gastrectomy on Glucose, Lipid, and Amino Acid Metabolism in Asian Individuals with Morbid Obesity.
    Yao J; Kovalik JP; Lai OF; Lee PC; Eng A; Chan WH; Tham KW; Lim E; Bee YM; Tan HC
    Obes Surg; 2019 Jan; 29(1):149-158. PubMed ID: 30191503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation.
    Cabré N; Luciano-Mateo F; Fernández-Arroyo S; Baiges-Gayà G; Hernández-Aguilera A; Fibla M; Fernández-Julià R; París M; Sabench F; Castillo DD; Menéndez JA; Camps J; Joven J
    Metabolism; 2019 Oct; 99():81-89. PubMed ID: 31279739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous Glutamine Administration Improves Glucose Tolerance and Attenuates the Inflammatory Response in Diet-Induced Obese Mice after Sleeve Gastrectomy.
    Yeh CL; Yang PJ; Lee PC; Wu JM; Chen PD; Huang CC; Yeh SL; Lin MT
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33086562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages.
    Krishnan S; Ding Y; Saedi N; Choi M; Sridharan GV; Sherr DH; Yarmush ML; Alaniz RC; Jayaraman A; Lee K
    Cell Rep; 2018 Apr; 23(4):1099-1111. PubMed ID: 29694888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
    Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
    Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.